Examining multi-objective deep reinforcement learning frameworks for molecular design.

Area of Science:

• Computational chemistry
• Artificial intelligence in drug discovery
• Molecular modeling

Background:

• Drug design involves exploring vast chemical spaces, often treated as multi-objective optimization problems.
• Deep reinforcement learning (DRL) offers potential for molecular design but struggles with training time and data efficiency.
• Fragment-based drug design and DRL are emerging strategies in computational chemistry.

Purpose of the Study:

• To examine deep and multi-objective reinforcement learning principles for molecular design.
• To analyze the performance of the DeepFMPO framework in optimizing protein-ligand docking affinity alongside other objectives.
• To compare a multi-objective DRL approach (DeepFMPO) with its single-objective counterpart.

Main Methods:

• Review of deep and multi-objective reinforcement learning methodologies in drug design.
• Application and performance analysis of the DeepFMPO framework in a real-world drug design scenario.
• Comparative analysis between the multi-objective DeepFMPO and a single-objective variant.

Main Results:

• The DeepFMPO framework, when optimizing for docking score, showed potential for success in drug design tasks.
• Training instability was observed in the DeepFMPO framework, indicating a need for further development.
• The multi-objective DRL approach demonstrated capabilities but highlighted challenges in consistent performance.

Conclusions:

• The DeepFMPO framework is a promising, albeit unstable, approach for multi-objective drug design.
• Further research is needed to address training instability and enhance the scalability of DRL-based drug design frameworks.
• Investigating and implementing modifications to stabilize DRL frameworks is crucial for their practical application in drug discovery.